Search This Blog

Thursday, May 2, 2013

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes (NYSE:LLY)

Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company launch educational campaign about emerging science in type 2 diabetes (NYSE:LLY)

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.